Biochemical Engineering

GSK cutting 720 jobs at massive Belgian vaccine hub

GSK cutting 720 jobs at massive Belgian vaccine hub

6th February 2020

GSK is starting a two-year restructuring program at its Belgian vaccine group that’ll reduce its headcount by up to 720 positions. The restructuring will affect R&D, manufacturing and global support functions, and most of the employees who will be affected are managers. Further, GSK doesn’t intend to renew 215 temporary contracts. Source: Fierce Pharma 6/2/2020


Back to group news